The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort
Journal of Nephrology · 2024
DOI: 10.1007/s40620-024-02071-x ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift Journal of Nephrology, 2024. Verfasst von Ivano Baragetti und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Bassini Hospital, Cinisello Balsamo, Italy. Hauptthemen laut MEDLINE: Glomerulonephritis, IGA, Immunosuppressive Agents, Adrenal Cortex Hormones. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 22 Literaturangaben.
Abstract (Originalsprache)
BACKGROUND: Systemic steroids are recommended for patients with IgA nephropathy (IgAN) and proteinuria. However, there are concerns about their safety due to an excess of serious adverse events (SAEs) in previous randomised trials. This study evaluates the incidence of SAEs in IgAN patients receiving different treatment regimens in clinical practice. METHODS: Multicentre, retrospective, observational cohort study of 1209 patients (M/F: 864/345, mean age: 41.73 ± 14.92 years) with biopsy-proven IgAN treated with renin angiotensin system (RAS) inhibitors (RASI) (n = 285), intravenous + oral steroids (n = 633), oral steroids (n = 99), steroids + immunosuppressants (n = 192). RESULTS: A total of 119 (9.8%) adverse events were reported, of which 67 (5.5%) were considered treatment-emergent, and 36 (2.9%) were SAEs (n = 23, 63.8% were infections). One patient died due to sepsis. A significant association was observed between AEs and immunosuppression [8 (2.8%) in RASI, 60 (9.4%) in steroids + immunosuppressants, 14 in oral steroids (14.1%) and 37 pts (19.2%) in steroids + immunosuppressants (p < 0.01)], age and estimated glomerular filtration rate (eGFR), but not with proteinuria and sex. On multivariate analysis, only older age was associated with the occurrence of SAEs. CONCLUSIONS: According to our findings, the incidence of SAEs during therapy with steroids alone or associated with immunosuppressors is lower in everyday clinical practice than in randomised clinical trials.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Bassini Hospital, Cinisello Balsamo, Italy.
- Department of Nephrology, Sant'Anna Hospital, ASST Lariana, Como, Italy. lucia.delvecchio@asst-lariana.it.
- Department of Nephrology, Civili Hospital, Brescia, Italy.
- Department of Nephrology, Busto Arsizio Hospital, Busto Arsizio, Italy.
- Department of Internal Medicine, Policlinico San Martino, Genoa, Italy.
- Department of Nephrology, A. Manzoni Hospital, Lecco, Italy.
ORCID-Profile: Lucia Del Vecchio
Zitieren
APA
Baragetti, I., Del Vecchio, L., Ferrario, F., Alberici, F., Amendola, A., Russo, E., Ponti, S., Di Palma, A. M., Pani, A., Rollino, C., Giannese, D., Boscutti, G., Sorrentino, A., Colturi, C., Brunori, G., Lazzarin, R., Catapano, F., Cozzolino, M., Feriozzi, S., …, & Italian Group of Steroids in IgAN (2024). The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort. Journal of Nephrology. https://doi.org/10.1007/s40620-024-02071-x
Vancouver
Baragetti I, Del Vecchio L, Ferrario F, Alberici F, Amendola A, Russo E, et al. The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort. Journal of Nephrology. 2024. doi:10.1007/s40620-024-02071-x
BibTeX
@article{Baragetti2024,
author = {Baragetti, Ivano and Del Vecchio, Lucia and Ferrario, Francesca and Alberici, Federico and Amendola, Andrea and Russo, Elisa and Ponti, Serena and Di Palma, Anna Maria and Pani, Antonello and Rollino, Cristiana and Giannese, Domenico and Boscutti, Giuliano and Sorrentino, Annasara and Colturi, Carla and Brunori, Giuliano and Lazzarin, Roberta and Catapano, Fausta and Cozzolino, Mario and Feriozzi, Sandro and Pozzi, Claudio and Italian Group of Steroids in IgAN, Italian Group of Steroids in IgAN},
title = {The safety of corticosteroid therapy in IGA nephropathy: analysis of a real-life Italian cohort},
journal = {Journal of Nephrology},
year = {2024},
doi = {10.1007/s40620-024-02071-x}
}
EUVIMED